Dow Up 0.26% Nasdaq Down 1.07%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
346.03 Down 0.03(0.01%) 3:59PM EDT
|After Hours : 344.00 Down 2.03 (0.59%) 6:12PM EDT
Prev Close:346.06
Open:347.07
Bid:342.00 x 1000
Ask:347.70 x 300
1y Target Est:366.11
Beta:0.65
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:340.39 - 347.50
52wk Range:257.69 - 369.31
Volume:539,439
Avg Vol (3m):844,075
Market Cap:34.74B
P/E (ttm):99.21
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
REGNDown 0.01%34.74B
AMGNUp 0.06%104.80B
NVSUp 0.45%228.50B
RHHBYUp 0.71%251.14B

Key Statistics

Forward P/E (1 yr):28.09
P/S (ttm):13.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.11
Quarterly EPS Est (Sep-14) :2.57
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback